SEC
CGEN icon

Seven Eight Capital’s Compugen CGEN Stock Holding History

Seven Eight Capital’s Portfolio CGEN Stock Details CGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-16,979
Closed -$276K – 434
2020
Q3 		$276K Buy
+16,979
New +$278K 0.06% 464

Other funds holding CGEN

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

Seven Eight Capital's CGEN Position: Q4 2020 in Review

Seven Eight Capital sold out of Compugen (CGEN) in Q4 2020, closing a stake of 16,979 shares — an estimated $276K sold.

Seven Eight Capital first reported a position in CGEN in Q3 2020 and held it in 1 quarter. The position peaked at $276K in Q3 2020. 101 funds tracked by Wall St. Rank hold CGEN as of Q4 2020.

  • Seven Eight Capital reported no remaining Compugen position as of Q4 2020 after selling out during the quarter.
  • Seven Eight Capital sold 16,979 Compugen shares in Q4 2020, an estimated $276K.
  • Seven Eight Capital first reported a position in Compugen in Q3 2020 and held it in 1 quarter.
  • Seven Eight Capital's Compugen position peaked at $276K in Q3 2020.
  • 101 funds tracked by Wall St. Rank held Compugen as of Q4 2020.

Based on Seven Eight Capital's 13F filing for Q4 2020, filed 9 Feb 2021.